Dr. Weijian Ye | Biomedical | Best Researcher Award

Dr. Weijian Ye, Biomedical, Best Researcher Award

Doctorate at The First Affiliated Hospital of Jinan University, China

Professional Profile

Summary:

Dr. Weijian YE is a distinguished researcher in the field of Chemical Genomics, with a Ph.D. from Peking University and a Bachelor’s degree from Guangzhou University of Chinese Medicine. With a strong background in Pharmaceutical Engineering, Dr. YE has made significant contributions to biomedical research, particularly in the development of PET tracers and radio pharmacy.

👩‍🎓Education:

  • Ph.D. in Chemical Genomics (Advisor: Prof. LEE, Chi-Sing)
    Peking University, Beijing, China
    Sep. 2014 – Jun. 2019
  • Bachelor’s Degree in Pharmaceutical Engineering (Advisor: Prof. WANG, Tao)
    Guangzhou University of Chinese Medicine, Guangzhou, China
    Sep. 2010 – Jun. 2014

🧬 Work Experience:

Senior Research Fellow
Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou
Sep. 2021 – Present

  • Leading research in radio synthesis, PET tracer development, translational medicine, and clinical research.
  • Developing synthetic routes for complex molecules and managing radiopharmaceutical projects from development to cGMP production.
  • Collaborating with departments for clinical research on novel PET tracers for neurological disorders and other diseases.

Post-doctoral Research Fellow (Supervisor: Prof. XU, Hao)
Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou
Jul. 2019 – Jul. 2021

  • Trained in radiochemistry, focusing on synthesizing and managing radioisotopes for pharmaceutical quality and safety.
  • Applied research in clinical translational medicine, bridging lab work to clinical applications.

🔬 Research Experience

 A.Development of PET Tracers/Radio Pharmacy
  1. Norepinephrine Transporter Targeted Tracer 18F-mFBG
    • Optimized labeling conditions, achieving a 17.8% radiochemical yield and >97% radiochemical purity within 70 mins.
    • Established SOP for clinical production, producing over 30 batches for more than 200 patients.
  2. Multi-functional Imaging Probe for Cu(II)
    • Designed and synthesized Cu(II)-specific probes for fluorescence and 19F MR imaging.
    • Applied the 18F-isotopologue to PET imaging in cynomolgus macaques.
  3. Vasopressin 1a Receptor Targeted Tracer
    • Developed an F-18 labeled PET tracer with high affinity for V1a receptor.
    • Conducted PET imaging and kinetic modeling studies in rhesus monkeys.
  4. TSPO Polymorphism-insensitive PET Tracers
    • Synthesized ligands for TSPO, demonstrating low sensitivity to TSPO rs6971 polymorphism.
    • Conducted PET imaging studies in rhesus monkeys and MCAO animal models.
  5. 11C-labeled Tracers for mGlu2 and FAAH
    • Contributed to the development and analysis of 11C-labeled PET tracers for mGlu2 and FAAH.
  6. New Synthons and Radiolabeling Strategies
    • Synthesized [18F]difluorocarbene and [18F]fluoro-[di-deutero]methyl tosylate, implementing automated radiolabeling programs.
B. Development of Fluorescent Probes
  1. Eu(III) Complex as Fluorescent Probe for Paralytic Shellfish Toxins
    • Designed and characterized europium complexes, proposing binding mechanisms using ion mobility mass spectrometry.
  2. Fluorescent Chemosensors for Polyamines
    • Synthesized TPE-conjugated pentiptycene derivatives, applied for spermine detection in artificial urine.
  3. Fluorescent Probes and 1H/19F MRI Contrast Agents for EBNA1 and EBV
    • Designed and synthesized Eu(III) and Gd(III) complexes for EBNA1, evaluating magnetic resonance properties.
C. Organic Syntheses
  1. Total Synthesis of Natural Product (±)-basiliolide B and Its Analogues
    • Performed a 15-step synthesis sequence, including large-scale reactions.
  2. Regioselective Pd-catalyzed (3+2) Cycloaddition of 2-pyrones with Vinylcyclopropanes
    • Achieved high yields and regioselectivity, broadening substrate scope for synthesis.

Publications Top Noted:

Paper Title: A PET-based radiomics nomogram for individualized predictions of seizure outcomes after temporal lobe epilepsy surgery
  • Authors: Huanhua Wu, Kai Liao, Zhiqiang Tan, Chunyuan Zeng, Biao Wu, Ziqing Zhou, Hailing Zhou, Yongjin Tang, Jian Gong, Weijian Ye, Xueying Ling, Qiang Guo, Hao Xu
  • Journal: Seizure: European Journal of Epilepsy
  • Volume: 119
  • Pages: 17-27
  • Year: 2024
Paper Title: Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
  • Authors: Lingling Zhang, Kuan Hu, Tuo Shao, Lu Hou, Shaojuan Zhang, Weijian Ye, Lee Josephson, Jeffrey H Meyer, Ming-Rong Zhang, Neil Vasdev, Jinghao Wang, Hao Xu, Lu Wang, Steven H Liang
  • Journal: Acta Pharmaceutica Sinica B
  • Volume: 11
  • Pages: 373-393
  • Year: 2021
  • Citations: 114
Paper Title: Positron emission tomography in the neuroimaging of autism spectrum disorder: a review
  • Authors: Zhiqiang Tan, Huiyi Wei, Xiubao Song, Wangxiang Mai, Jiajian Yan, Weijian Ye, Xueying Ling, Lu Hou, Shaojuan Zhang, Sen Yan, Hao Xu, Lu Wang
  • Volume: 16
  • Pages: 806876
  • Year: 2022
  • Citations: 14
Paper Title: Sensitive and responsive pentiptycene-based molecular fluorescence chemosensor for detection of polyamines
  • Authors: Junrong Huang, Weijian Ye, Shuai Zha, Yezi Tao, Min Yang, Ke Huang, Jiqiang Liu, Yan-Ho Fung, Yang Li, Penghao Li, Lizhi Zhu, Chi-Sing Lee
  • Journal: Journal of Luminescence
  • Volume: 232
  • Pages: 117856
  • Year: 2021
  • Citations: 12
Paper Title: Recent developments on the application of molecular probes in multiple myeloma: Beyond [18F] FDG
  • Authors: Shaojuan Zhang, Jingjie Shang, Weijian Ye, Tianming Zhao, Hao Xu, Hui Zeng, Lu Wang
  • Volume: 10
  • Pages: 920882
  • Year: 2022
  • Citations: 1